Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    NCT01504347
Previous Study | Return to List | Next Study

Phase 1/2 Lyme Vaccine Study

This study has been completed.
Baxter Innovations GmbH
Information provided by (Responsible Party):
Baxalta US Inc. Identifier:
First received: December 22, 2011
Last updated: June 26, 2015
Last verified: March 2014